Does TOFACITINIB Cause Pulmonary mass? 214 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Pulmonary mass have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
214
Reports of Pulmonary mass with TOFACITINIB
0.1%
of all TOFACITINIB reports
7
Deaths
51
Hospitalizations
How Dangerous Is Pulmonary mass From TOFACITINIB?
Of the 214 reports, 7 (3.3%) resulted in death, 51 (23.8%) required hospitalization, and 8 (3.7%) were considered life-threatening.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 214 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
MEPOLIZUMAB (450)
LEFLUNOMIDE (430)
Which TOFACITINIB Alternatives Have Lower Pulmonary mass Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN